1 Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL,
et al.; Authors/Task Force Members. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81. doi:.
2 Smith SC, Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011;58(23):2432–46. doi:. Correction in:
J Am Coll Cardiol. 2015;65(14):1495 (dosage error in article text).
3 Berra K, Rippe J, Manson JE. Making Physical Activity Counseling
a Priority in Clinical Practice: The Time for Action Is Now. JAMA. 2015;314(24):2617–8. doi:.
4 de Souto Barreto P. Global health agenda on non-communicable diseases: has WHO set a smart goal for physical activity?
BMJ. 2015;350:h23. doi:.
5 Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100(2):126–31.
6 Eijsvogels TM, Molossi S, Lee DC, Emery MS, Thompson PD. Exercise at the Extremes: The Amount of Exercise to Reduce Cardiovascular Events. J Am Coll Cardiol. 2016;67(3):316–29. doi:.
7 Sattelmair J, Pertman J, Ding EL, Kohl HW, 3rd, Haskell W, Lee IM. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation. 2011;124(7):789–95. doi:.
8 Lee DC, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN. Leisure-time running reduces all-cause and cardiovascular mortality risk.
J Am Coll Cardiol. 2014;64(5):472–81. doi:. Erratum in: J Am Coll Cardiol. 2014;64(14):1537.
9 Wen CP, Wai JP, Tsai MK, Chen CH. Minimal amount of exercise to prolong life: to walk, to run, or just mix it up? J Am Coll Cardiol. 2014;64(5):482–4. doi:.
10 van der Ploeg HP, Chey T, Ding D, Chau JY, Stamatakis E, Bauman AE. Standing time and all-cause mortality in a large cohort of Australian adults. Prev Med. 2014;69:187–91. doi:.
11 Myers J. Cardiology patient pages. Exercise and cardiovascular health. Circulation. 2003;107(1):e2–5. doi:.
12 Moore SC, Patel AV, Matthews CE, Berrington de Gonzalez A, Park Y, Katki HA, et al. Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med. 2012;9(11):e1001335. doi:.
13 Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women:
a meta-analysis. JAMA. 2009;301(19):2024–35. doi:.
14 Sharma S, Merghani A, Mont L. Exercise and the heart: the good, the bad, and the ugly. Eur Heart J. 2015;36(23):1445–53. doi:.
15 Karvinen S, Waller K, Silvennoinen M, Koch LG, Britton SL,
Kaprio J, et al. Physical activity in adulthood: genes and mortality. Sci Rep. 2015;5:18259. doi:.
16 Rognmo Ø, Moholdt T, Bakken H, Hole T, Mølstad P, Myhr NE, et al. Cardiovascular risk of high- versus moderate-intensity aerobic exercise in coronary heart disease patients. Circulation. 2012;126(12):1436–40. doi:.
17 Noël M, Jobin J, Marcoux A, Poirier P, Dagenais GR, Bogaty P. Can prolonged exercise-induced myocardial ischaemia be innocuous? Eur Heart J. 2007;28(13):1559–65. doi:.
18 Gerardin B, Collet JP, Mustafic H, Bellemain-Appaix A, Benamer H, Monsegu J, et al.; Groupe de Réflexion sur la Cardiologie Interventionnelle. Registry on acute cardiovascular events during endurance running races: the prospective RACE Paris registry.
Eur Heart J. 2016;37(32):2531–41. doi:.
19 Kim JH, Malhotra R, Chiampas G, d’Hemecourt P, Troyanos C, Cianca J, et al.; Race Associated Cardiac Arrest Event Registry (RACER) Study Group. Cardiac arrest during long-distance running races.
N Engl J Med. 2012;366(2):130–40. doi:.
20 Deo R, Albert CM. Epidemiology and genetics of sudden cardiac death. Circulation. 2012;125(4):620–37. doi:.
21 Becker LB, Han BH, Meyer PM, Wright FA, Rhodes KV, Smith DW,
et al. Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. N Engl J Med. 1993;329(9):600–6. doi:.
22 Albert CM, McGovern BA, Newell JB, Ruskin JN. Sex differences
in cardiac arrest survivors. Circulation. 1996;93(6):1170–6. doi:.
23 Pelliccia A, Kinoshita N, Pisicchio C, Quattrini F, Dipaolo FM, Ciardo R, et al. Long-term clinical consequences of intense, uninterrupted endurance training in olympic athletes. J Am Coll Cardiol. 2010;55(15):1619–25. doi:.
24 Karjalainen J, Kujala UM, Kaprio J, Sarna S, Viitasalo M. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ. 1998;316(7147):1784–5. doi:.
25 Andersen K, Farahmand B, Ahlbom A, Held C, Ljunghall S, Michaëlsson K, et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J. 2013;34(47):3624–31. doi:.
26 Möhlenkamp S, Lehmann N, Breuckmann F, Bröcker-Preuss M, Nassenstein K, Halle M, et al.; Marathon Study Investigators; Heinz Nixdorf Recall Study Investigators. Running: the risk of coronary events : Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J. 2008;29(15):1903–10. doi:.
27 Schnohr P, O’Keefe JH, Marott JL, Lange P, Jensen GB. Dose of jogging and long-term mortality: the Copenhagen City Heart Study.
J Am Coll Cardiol. 2015;65(5):411–9. doi:.
28 van Saase JL, Noteboom WM, Vandenbroucke JP. Longevity of men capable of prolonged vigorous physical exercise: a 32 year follow up of 2259 participants in the Dutch eleven cities ice skating tour. BMJ. 1990;301(6766):1409–11. doi:.
29 Clarke PM, Walter SJ, Hayen A, Mallon WJ, Heijmans J, Studdert DM. Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era. BMJ. 2012;345(dec13 8):
e8308. doi:.
30 Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2016;67(1):1–12. doi:.
31 Gencer B, Rodondi N, Auer R, Nanchen D, Räber L, Klingenberg R, et al. Health utility indexes in patients with acute coronary syndromes. Open Heart. 2016;3(1):e000419. doi:.
32 Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F,
et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315. doi:.
33 Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035–87. doi:.
34 Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society
of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119.
doi:.
35 Meyer P, Kayser B, Kossovsky MP, Sigaud P, Carballo D, Keller PF,
et al. Stairs instead of elevators at workplace: cardioprotective effects of a pragmatic intervention. Eur J Cardiovasc Prev Rehabil. 2010;17(5):569–75. doi:.
36 Kamani CH, Gencer B, Montecucco F, Courvoisier D, Vuilleumier N, Meyer P, et al. Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population. Eur J Clin Invest. 2015;45(10):1017–24. doi:.
37 Sedaghat-Hamedani F, Kayvanpour E, Frankenstein L, Mereles D, Amr A, Buss S, et al. Biomarker changes after strenuous exercise can mimic pulmonary embolism and cardiac injury – a metaanalysis of 45 studies. Clin Chem. 2015;61(10):1246–55. doi:.
38 Sou SM, Puelacher C, Twerenbold R, Wagener M, Honegger U, Reichlin T, et al. Direct comparison of cardiac troponin I and cardiac troponin T in the detection of exercise-induced myocardial ischemia. Clin Biochem. 2016;49(6):421–32. doi:.
39 CardioPulse Articles. Eur Heart J. 2016;37(20):1556–64.
doi:http://dx.doi.org/10.1093/eurheartj/ehw144.
Mit der Kommentarfunktion bieten wir Raum für einen offenen und kritischen Fachaustausch. Dieser steht allen SHW Beta Abonnentinnen und Abonnenten offen. Wir publizieren Kommentare solange sie unseren Richtlinien entsprechen.